![John Sharp](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Sharp
Finanzdirektor/CFO bei
SKYE BIOSCIENCE, INC.
Profil
John P.
Sharp is currently Chief Financial Officer & Vice President at Metabasis Therapeutics, Inc. since 2010.
Mr. Sharp is a Member of The Association of Bioscience Financial Officers.
Mr. Sharp is Chief Financial Officer at Skye Bioscience, Inc. starting in 2026.
Mr. Sharp is Chief Financial Officer at Cadrenal Therapeutics, Inc. starting in 2026.
Formerly, Mr. Sharp was Accounting Director at Diversa Corp.
in 2004.
Mr. Sharp was Chief Financial Officer & Vice President at Ligand Pharmaceuticals, Inc. from 2010 to 2014.
Mr. Sharp was Chief Accounting Officer & Vice President at Sequenom, Inc. from 2004 to 2007.
Mr. Sharp was Senior Audit Manager at PricewaterhouseCoopers LLP from 1994 to 2000.
Mr. Sharp was Chief Financial Officer at PhaseBio Pharmaceuticals, Inc. from 2016 to 2022.
Mr. Sharp was Chief Financial Officer at Huyabio International LLC from 2014 to 2015.
Mr. Sharp completed undergraduate studies at San Diego State University.
Aktive Positionen von John Sharp
| Unternehmen | Position | Beginn |
|---|---|---|
| SKYE BIOSCIENCE, INC. | Finanzdirektor/CFO | 31.03.2026 |
| CADRENAL THERAPEUTICS, INC. | Finanzdirektor/CFO | 25.06.2026 |
The Association of Bioscience Financial Officers
 The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services Operates as a association for bioscience financial officers | Corporate Officer/Principal | - |
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs | Finanzdirektor/CFO | 29.01.2010 |
Ehemalige bekannte Positionen von John Sharp
| Unternehmen | Position | Ende |
|---|---|---|
| PHASEBIO PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 30.11.2022 |
Huyabio International LLC
 Huyabio International LLC Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Finanzdirektor/CFO | 01.12.2015 |
| LIGAND PHARMACEUTICALS INCORPORATED | Finanzdirektor/CFO | 28.02.2014 |
| SEQUENOM, INC. | Comptroller/Controller/Auditor | 17.04.2007 |
Diversa Corp.
 Diversa Corp. Miscellaneous Commercial ServicesCommercial Services Researches and develops genomic tools and biological technology for the agricultural industry | Comptroller/Controller/Auditor | 01.11.2004 |
Ausbildung von John Sharp
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
100
+
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Ligand Pharmaceuticals, Inc.
 Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies | Health Technology |
Sequenom, Inc.
 Sequenom, Inc. Medical/Nursing ServicesHealth Services Provides genomic and genetic analysis solutions | Health Services |
Diversa Corp.
Diversa Corp. Miscellaneous Commercial ServicesCommercial Services Researches and develops genomic tools and biological technology for the agricultural industry | Commercial Services |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs | Health Technology |
PhaseBio Pharmaceuticals, Inc.
 PhaseBio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapies for cardiovascular diseases | Health Technology |
Huyabio International LLC
Huyabio International LLC Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
San Diego State University
 San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Association of Bioscience Financial Officers
The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services Operates as a association for bioscience financial officers | Commercial Services |
Skye Bioscience, Inc.
 Skye Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets cannabinoid derivatives to treat ophthalmic disorders | Health Technology |
Cadrenal Therapeutics, Inc.
 Cadrenal Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel therapy with orphan drug indication | Health Technology |
